Bracanat 150mg Tablet 30s

Introduction to Bracanat 150mg Tablet 30s

Bracanat 150mg Tablet 30s is a pharmaceutical product in tablet form, primarily used for the treatment of certain types of cancer, including ovarian, breast, and prostate cancer. It is particularly beneficial for patients with BRCA mutations, which are genetic changes that increase cancer risk.

Composition of Bracanat 150mg Tablet 30s

The active ingredient in Bracanat 150mg Tablet 30s is Olaparib, a PARP inhibitor that blocks an enzyme cancer cells use to repair their DNA, thereby slowing or stopping their growth.

Uses of Bracanat 150mg Tablet 30s

• Treatment of ovarian cancer
• Treatment of breast cancer
• Treatment of prostate cancer
• Effective in patients with BRCA mutations

Side effects of Bracanat 150mg Tablet 30s

• Nausea
• Fatigue
• Anemia (low red blood cell count)
• Potential bone marrow problems
• Increased risk of infection

Precautions of Bracanat 150mg Tablet 30s

Patients with severe liver or kidney issues should avoid using Bracanat 150mg Tablet 30s. Pregnant women should not use this medication due to potential harm to the unborn baby. Always consult your doctor about any concerns or conditions that might affect your use of this medicine.

How to Take Bracanat 150mg Tablet 30s

The usual starting dose for adults is 300 mg taken twice daily. It is taken as a tablet, with or without food. Swallow the tablets whole; do not crush or chew them. Always follow your doctor's specific dosing instructions.

Conclusion of Bracanat 150mg Tablet 30s

Bracanat 150mg Tablet 30s, containing Olaparib, is a therapeutic option for treating certain cancers, particularly in patients with BRCA mutations. Manufactured by Natco Pharma Ltd, it is crucial to follow medical advice for its use. This medicine offers a targeted approach to cancer treatment by inhibiting DNA repair in cancer cells.